Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
